1-3 of 3
Mingzhao Zhu
Close
Sort by
Journal Articles

Targeting eIF4A Using MZ-735 Potently Induces Cell Death in Lymphoma Cells and Rapidly Represses mRNA Translation at the Global Level and in C-MYC and Other Oncogenes

Ipsita Pal, PhD, Yu Ri Kim, MD, Sohani Das Sharma, PhD, Prabhjot S. Mundi, MD, Andre M. Grilo, PhD, Luke E Berchowitz, PhD, Mingzhao Zhu, PhD, Hull G. Kenneth, PhD, Daniel Romo, PhD, Owen O'Connor, MD PhD, Marko Jovanovic, PhD, Changchun Deng, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4067.
https://doi.org/10.1182/blood-2019-131816
Published: 2019
Journal Articles

Silencing Oncogene Translation Using Pateamine a Analogues As a Novel Therapeutic Strategy for c-Myc Driven Lymphoma

Yu Ri Kim, MD, Ipsita Pal, PhD, Mark R Lipstein, PhD, Mingzhao Zhu, Hull Kenneth, Daniel Romo, Owen A. O'Connor, MD, PhD, Changchun Deng, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4111.
https://doi.org/10.1182/blood.V130.Suppl_1.4111.4111
Published: 2017
Journal Articles

Piperlongumine Blocks JAK2-STAT3 Pathway to Inhibit Collagen-Induced Platelet Reactivity Independent of Reactive Oxygen Species

Hengjie Yuan, MD PhD, Katie Houck, BS, Ye Tian, MD PhD, Zhou Zhou, MDPhD, Mingzhao Zhu, Vimal Patel, Uddalak Bharadwaj, PhD, David John Tweardy, MD, Daniel Romo, PhD, Xiaoyun Fu, PhD, Yanjun Zhang, PhD, Jianning Zhang, MD PhD, Jing-fei Dong, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2755.
https://doi.org/10.1182/blood.V124.21.2755.2755
Published: 2014